PSA cancer screening: a case for shared decision-making.

Publisher: Frontline Medical Communications Country of Publication: United States NLM ID: 7502590 Publication Model: Print Cited Medium: Internet ISSN: 1533-7294 (Electronic) Linking ISSN: 00943509 NLM ISO Abbreviation: J Fam Pract Subsets: MEDLINE

Publication: Parsippany, NJ : Frontline Medical Communications
Original Publication: New York, Appleton-Century-Crofts.

Decision Making, Shared*; Early Detection of Cancer/*methods ; Prostate-Specific Antigen/*analysis ; Prostatic Neoplasms/*diagnosis; Aged ; Aged, 80 and over ; Digital Rectal Examination/standards ; Digital Rectal Examination/statistics & numerical data ; Early Detection of Cancer/psychology ; Early Detection of Cancer/standards ; Humans ; Male ; Middle Aged ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms/mortality ; Prostatic Neoplasms/physiopathology

Whether to screen for prostate cancer using PSA testing is a difficult decision for many men. Here's the information you need to help them make an educated choice.

EC 3.4.21.77 (Prostate-Specific Antigen)

Date Created: 20200205 Date Completed: 20200706 Latest Revision: 20200706

20240105

32017831